Morning Sickness Completed Phase 4 Trials for Pyridoxine (DB00165)

Also known as: Unspecified pregnancy vomiting NOS / Vomiting in pregnancy / Vomiting of pregnancy, unspecified / Unspecified vomiting of pregnancy

Indication	Status	Phase
DBCOND0060154 (Morning Sickness)	Completed	4

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT02300155	Improving Multivitamin Supplementation to Pregnant Women	Treatment	Ascorbic acid (DB00126) Beta carotene (DB06755) Calcium carbonate (DB06724) Cholecalciferol (DB00169) Cupric oxide (DB11134) Cyanocobalamin (DB00115) Ferrous fumarate (DB14491) Ferrous sulfate anhydrous (DB13257) Folic acid (DB00158) Magnesium oxide (DB01377) Nicotinamide (DB02701) Pantothenic acid (DB01783) Potassium Iodide (DB06715) Pyridoxine (DB00165) Riboflavin (DB00140) Thiamine (DB00152) Vitamin A (DB00162) Zinc oxide (DB09321) Zinc sulfate (DB09322) alpha-Tocopherol acetate (DB14003)